Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.
10. Februar 2020 01:17 ET
|
Esperite N.V.
Samples and Database are safe Amsterdam, The Netherlands – 10 February 2020 Esperite N.V. (Euronext: ESP, “Esperite”) has noticed several articles in the news, online channels and information blogs...
ESPERITE (ESP) is not bankrupt
30. Oktober 2019 03:59 ET
|
Esperite N.V.
ESPERITE (ESP) is not bankrupt. Amsterdam, The Netherlands – 30 October 2019 The court in Zutphen has annuled...
Esperite (ESP) disputes the Court verdict and appeals the bankruptcy order.
13. Oktober 2019 23:59 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 14 October 2019 The Court in Gelderland, Netherlands, on October 8th, 2019, has declared Esperite in bankruptcy. The board of directors of Esperite N.V. disputes the...
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
01. Oktober 2019 04:33 ET
|
Esperite N.V.
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Amsterdam, The Netherlands – 1st October 2019 Esperite N.V. (the Group) confirmed on 22nd February...
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
19. September 2019 07:26 ET
|
Esperite N.V.
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business. Switzerland – 19 September 2019 CryoSave has since its...
ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS
27. August 2019 09:54 ET
|
Esperite N.V.
ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS Amsterdam, the Netherlands – 27 August 2019 Esperite N.V. (Euronext: ESP) and...
Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
04. Juli 2019 02:58 ET
|
Esperite N.V.
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report Amsterdam, The Netherlands – 3 July 2019Esperite N.V. (Euronext: ESP, “Esperite”) announces that its...
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
02. Juli 2019 02:47 ET
|
Esperite N.V.
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. ...
ESPERITE NV (ESP) MIT CRYOSAVE BESTÄTIGT DIE SICHERHEIT ALLER GELAGERTEN PROBEN UND DANKT DEN 260'000 FAMILIEN FÜR IHR VERTRAUEN.
01. Juli 2019 01:17 ET
|
Esperite N.V.
ESPERITE NV (ESP) MIT CRYOSAVE BESTÄTIGT DIE SICHERHEIT ALLER GELAGERTEN PROBEN UND DANKT DEN 260'000 FAMILIEN FÜR IHR VERTRAUEN. CryoSave wählte PBKM als geeigneten Subunternehmer für die...
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE.
01. Juli 2019 01:17 ET
|
Esperite N.V.
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE. CryoSave chose PBKM as the appropriate subcontractor...